The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - ARIAD
Stock and Other Ownership Interests - ARIAD
Activity of brigatinib (BRG) in crizotinib (CRZ) resistant patients (pts) according to ALK mutation status.
 
Scott N. Gettinger
Consulting or Advisory Role - ARIAD; Bristol-Myers Squibb; Janssen
Research Funding - ARIAD (Inst); AstraZeneca/MedImmune (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Incyte (Inst); Pfizer (Inst)
 
Sen Zhang
Employment - ARIAD
Stock and Other Ownership Interests - ARIAD
 
J. Graeme Hodgson
Employment - ARIAD
Stock and Other Ownership Interests - ARIAD
 
Lyudmila Bazhenova
Stock and Other Ownership Interests - Epic Sciences
Consulting or Advisory Role - AstraZeneca; Genoptix; Heat Biologics; Pfizer
Speakers' Bureau - Genentech; Novartis
 
Sjaak Burgers
No Relationships to Disclose
 
Dong-Wan Kim
No Relationships to Disclose
 
Daniel Shao-Weng Tan
Consulting or Advisory Role - Boehringer Ingelheim; Novartis; Pfizer
Research Funding - Bayer (Inst); GlaxoSmithKline (Inst); Novartis (Inst)
 
Han A. Koh
No Relationships to Disclose
 
James C. M. Ho
Honoraria - AstraZeneca; Boehringer Ingelheim; Lilly; MSD; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Lilly; MSD; Pfizer; Roche
Research Funding - ARIAD (Inst); AstraZeneca (Inst); AVEO (Inst); MSD (Inst); Roche (Inst)
 
Santiago Viteri Ramirez
Consulting or Advisory Role - Boehringer Ingelheim; Clovis Oncology; Idea Pharma; Novartis; Targovax
 
Alice Tsang Shaw
Honoraria - Novartis; Pfizer; Roche/Genentech
Consulting or Advisory Role - ARIAD; Blueprint Medicines; Daiichi Sankyo; Genentech; Ignyta; Novartis; Pfizer; Roche
 
Glen J. Weiss
Employment - Cancer Treament Centers of America
Consulting or Advisory Role - Blend Therapeutics; Paradigm; Pharmatech
Speakers' Bureau - Amgen; Celgene; Medscape; Pfizer; Quintiles
Patents, Royalties, Other Intellectual Property - US Patent #8,911,940 issued 2014 (Inst)
Travel, Accommodations, Expenses - Cambridge Healthtech Institute; Pharmatech
 
Corey J. Langer
Honoraria - Bristol-Myers Squibb; Genentech/Roche; Lilly/ImClone
Consulting or Advisory Role - Abbott Biotherapeutics; Bayer/Onyx; Cancer Support Community; Celgene; Clarient; Clovis Oncology; Genentech/Roche; Lilly/ImClone; Merck; Millennium
Research Funding - Advantagene (Inst); Ariad (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Clovis Oncology (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Inovio Pharmaceuticals (Inst); Merck (Inst)
 
Rudolf M. Huber
Honoraria - ARIAD; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Pfizer; Roche
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Clovis Oncology; Lilly; Novartis; Roche
Research Funding - Pierre Fabre (Inst)
 
Myung-Ju Ahn
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Novartis
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Novartis
Research Funding - AstraZeneca (Inst)
 
William G Reichmann
No Relationships to Disclose
 
David Kerstein
Employment - ARIAD
Stock and Other Ownership Interests - ARIAD
 
Victor M. Rivera
Employment - ARIAD
Leadership - ARIAD
Stock and Other Ownership Interests - ARIAD
 
D. Ross Camidge
Honoraria - ARIAD
Research Funding - ARIAD (Inst)